GLAZER CAPITAL, LLC - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 20 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GLAZER CAPITAL, LLC ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q3 2022$85,000
+51.8%
8,502
+49.1%
0.00%
+100.0%
Q2 2022$56,000
+86.7%
5,702
+89.4%
0.00%0.0%
Q1 2022$30,000
-96.2%
3,010
-96.2%
0.00%
-92.9%
Q3 2021$791,000
-2.8%
79,7790.0%0.01%
+7.7%
Q2 2021$814,000
-1.8%
79,779
-3.2%
0.01%
+8.3%
Q1 2021$829,000
-65.5%
82,379
-63.5%
0.01%
-86.0%
Q4 2020$2,406,000225,6850.09%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q1 2022
NameSharesValueWeighting ↓
Altium Capital Management LP 400,000$4,264,0001.59%
Endurant Capital Management LP 195,000$2,079,0000.75%
CVI Holdings, LLC 355,000$3,784,0000.71%
Wealthspring Capital LLC 129,880$1,385,0000.69%
Sio Capital Management, LLC 300,000$3,198,0000.66%
Monashee Investment Management LLC 300,000$3,198,0000.42%
Sage Mountain Advisors LLC 95,970$1,023,0000.34%
683 Capital Management, LLC 600,000$6,396,0000.30%
LONGFELLOW INVESTMENT MANAGEMENT CO LLC 200,000$2,138,0000.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$2,132,0000.23%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders